S&P 500 (NYSE:SPY) component DENTSPLY International, Inc. (NASDAQ:XRAY) will unveil its latest earnings on Thursday, February 16, 2012. DENTSPLY International manufactures and distributes dental equipment and products, including artificial teeth and dental consumable products.
DENTSPLY International, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 52 cents per share, a rise of 2% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. Analysts are projecting profit to rise by 6.8% versus last year to $2.03.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 3 cents, reporting net income of 46 cents per share against a mean estimate of profit of 43 cents per share.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a rise of 27.5% in revenue from the year-earlier quarter to $724.6 million.
Analyst Ratings: Analysts are bullish on DENTSPLY International, as seven analysts rate it as a buy, one rates it as a sell and three rate it as a hold.
A Look Back: In the third quarter, profit fell 4.8% to $60.6 million (42 cents a share) from $63.7 million (44 cents a share) the year earlier, but exceeded analyst expectations. Revenue rose 14.4% to $619.8 million from $541.8 million.
Revenue has increased for three consecutive quarters. It rose 7.8% in the second quarter from the year earlier and 4.5% in the first quarter.
Stock Price Performance: Between December 13, 2011 and February 10, 2012, the stock price had risen $2.55 (7.3%), from $35.13 to $37.68. The stock price saw one of its best stretches over the last year between June 27, 2011 and July 8, 2011, when shares rose for nine straight days, increasing 5.6% (+$2.07) over that span. It saw one of its worst periods between December 9, 2011 and December 19, 2011 when shares fell for seven straight days, dropping 4.5% (-$1.64) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)